Jennifer Kayden Lee, EVP, Head of North America at Rhythm Pharmaceuticals, sold RYTM on Aug 13, 2026
Data as of Oct 16
▼ SELL$8.9M75,834 shares at $117.38Jennifer Kayden Lee EVP, Head of North AmericaRYTM Rhythm Pharmaceuticals, Inc.
- Traded
- Aug 13, 2026
- Disclosed
- Aug 14, 2026
- Filed
- 1 day after the trade
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
RYTM since disclosure
−25.4%
after the sale
Similar stocks (XLV) since disclosure
+5.6%
XLV — its sector index fund
Change in closing price from Aug 14, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.